Study ID: BFS-AS-40074 | DRKS00006542
Study Title
- Study to Evaluate Satisfaction and Usability of DuoRespֲ® SPIROMAXֲ® in Asthma and COPD Treatment
Teva Identifier
- BFS-AS-40074 | DRKS00006542
ClinicalTrials.gov Identifier
- NCT02384577
Study Status
- Completed
Trial Condition(s)
- Patient Satisfaction
Interventions
- Drug: Budesonide, Formoterol Fumarate Dihydrate
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 07/01/2014 - 09/01/2016
Study Type
Observational